explore -WSS

explore

author：entertainment 2025-09-30 00:48:21 - browse：85224

Are venture capitalists OK? Are bolt-ons good for business? And when is it safe to say someone overpaid?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. We discuss how biotech’s downturn has made life difficult not just for startups but also the VCs they rely on for much-needed funding. We also take a look at Gilead Sciences’ struggle to turn itself into an oncology company and the latest biotech to get bought out by a major pharma firm.

For more on what we cover, here’s more on Gilead; here’s the news on Inhibrx; here’s the latest on biotech venture capital; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： Updated Covid vaccine has 54% effectiveness, new study suggests

explore

Wikipedia

focus

WSS

Bernie brings in new pharma CEOs to talk drug prices

Johnson & Johnson sued for allegedly overpaying for workers' drugs

Why CTE doesn’t keep Americans from enjoying the Super Bowl

Petition to FDA: Get the lead out of consumer hair dyes

Oak trusses raised to roof of fire

Vyjuvek, a gene therapy for skin wounds, restored vision in one boy

focus

explore

explore

Novavax promises a turnaround & Lilly roils the obesity market

Why ADHD is under

Affirmative action in medical school literally saved lives

The CDC's new social media misinformation war

Guidelines to prevent youth baseball injuries need more muscle

Palantir health business leans on meeting customers’ needs

The cancer drug shortage isn’t new — and neither are the solutions

Novo Holdings to buy drug manufacturer Catalent in $16.5B deal

George Santos makes 1st court appearance after pleading not guilty to 13 counts

A single Democrat is willing to weaken Medicare negotiation power

knowledge

Adopting new red light myopia treatments may be short

Leqembi, other new Alzheimer’s drugs require better biomarkers

Insurance companies sue energy corporation after it was blamed for helping start Colorado wildfire

Living with Fabry disease, a condition that causes chronic pain

Iowa House, Senate pass 6

N.Y. state detects polio case, first in the U.S. since 2013

explore

Wikipedia

focus

focus